BCG

12 registered clinical trials studyying BCG — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Enrolling By Invitation	BCG Revaccination With the Third Dose of Diphtheria-tetanus-pertussis Vaccine and Infant Mortality in Africa NCT07005726	Bandim Health Project	Phase 4
Recruiting	BCG for Therapeutic Use Phase Ⅲ Clinical Trial NCT06747455	Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.	Phase 3
Not Yet Recruiting	Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive B NCT06374914	Dokuz Eylul University	—
Completed	SARS-CoV-2/COVID-19 Infection Among Health Care Workers NCT04826718	Universidade de Cabo Verde	—
Active Not Recruiting	Can BCG Vaccination at First Health-facility Contact Reduce Early Infant Mortality? NCT04658680	Bandim Health Project	Phase 4
Completed	COVID-19: BCG As Therapeutic Vaccine, Transmission Limitation, and Immunoglobulin Enhancement NCT04369794	University of Campinas, Brazil	Phase 4
Unknown	Prevention, Efficacy and Safety of BCG Vaccine in COVID-19 Among Healthcare Workers NCT04461379	Hospital Universitario Dr. Jose E. Gonzalez	Phase 3
Completed	Neutrophils to Lymphocytes Ratio in Predicting the Response to BCG in Non-muscle Invasive Bladder Cancer NCT05946369	Ain Shams University	—
Completed	Vitamin D3 For CGD Patients With BCGosis/Itis NCT03984890	Children's Hospital of Fudan University	Phase 2 / Phase 3
Terminated	Prevention and Management of Intravesical BCG-related Lower Urinary Tract Symptoms NCT03549650	Sir Mortimer B. Davis - Jewish General Hospital	Phase 2
Unknown	A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) NCT03121768	Mansoura University	—
Terminated	Can Earlier BCG Vaccination Reduce Early Infant Mortality? A Randomised Trial NCT02504203	Bandim Health Project	Phase 4